Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Science 2005 Oct;310(5748):644-8

Department of Pathology, University of Michigan Medical School, 1301 Catherine Street, Ann Arbor, MI 48109-0602, USA.

Recurrent chromosomal rearrangements have not been well characterized in common carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression. Two ETS transcription factors, ERG and ETV1, were identified as outliers in prostate cancer. We identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression. By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1. Cell line experiments suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer. These results have implications in the development of carcinomas and the molecular diagnosis and treatment of prostate cancer.

Download full-text PDF

Source
http://www.sciencemag.org/cgi/doi/10.1126/science.1117679
Publisher Site
http://dx.doi.org/10.1126/science.1117679DOI Listing
October 2005
17 Reads

Publication Analysis

Top Keywords

prostate cancer
24
erg etv1
12
ets transcription
8
prostate
6
cancer
6
etv1 prostate
4
demonstrated prostate
4
tmprss2 erg
4
cancer tissues
4
tissues outlier
4
fluorescence situ
4
situ hybridization
4
expression fluorescence
4
region tmprss2
4
outlier expression
4
hybridization demonstrated
4
untranslated region
4
identified outliers
4
etv1 identified
4
factors erg
4

Similar Publications